SIETES :: 93059 citas

Resultados de la búsqueda por ESCOCIA REFINAR BÚSQUEDA

1.

Smith BH, Fletcher EH, Calvin LA. Opioid prescribing is rising in many countries. BMJ 2019;367:17 de octubre. [Ref.ID 103203]

2.

Wei L, Ratnayake L, Phillips G, McGuigan CC, Morant SV, Flynn RW, Mackenzie IS, MacDonald TM. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol 2017;83:1298-308. [Ref.ID 101942]

3.

Guthrie B, Kavanagh K, Robertson C, Barnett K, Treweek S, Petrie D, Ritchie L, Mackenzie J, Bennie M. Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ 2016;354:i4079. [Ref.ID 100606]

4.

Pakpoor J. Health professionals call for urgent halt to fracking because of public health concerns. BMJ 2015;350:h1791. [Ref.ID 98942]

5.

Spence D. Bad medicine: nalmefene in alcohol misuse. BMJ 2014;348:g1531. [Ref.ID 97333]

6.

Anónimo. Drug assessment: UK style. Drug Ther Bull 2013;51:141-4. [Ref.ID 96627]

7.

Guthrie B, MCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011;342:1406. [Ref.ID 90913]

8.

Short PM, Lipworth SIW, Elder DHJ, Schembri S, Lipworth BJ. Effect of ß blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2011;342:2549. [Ref.ID 90568]

9.

Macaulay D. Glucagon-like peptide-1 drugs. Are GLP-1 analogues affordable?. BMJ 2011;342:563. [Ref.ID 90293]

10.

11.

Anónimo. Risque de cancers chez des patients diabétiques traités par insuline glargine?. Prescrire 2010;30:268-70. [Ref.ID 88326]

12.

de Andrade M. In clear sight. BMJ 2009;339:538-40. [Ref.ID 86726]

13.

Gale EAM. Insulin glargine and cancer: another side. Lancet 2009;374:521. [Ref.ID 86486]

14.

Pocock SJ, Smeeth L. Insulin glargine and malignancy: an unwarranted alarm. Lancet 2009;374:511-3. [Ref.ID 86414]

15.

McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ 2009;338:1548-51. [Ref.ID 86146]

16.

Colhoun HM, on behalf of the SDRN Epidemiology Group. Use of insulin glargine and cancer incidence in Scotland: A study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2009;52:1755-65. [Ref.ID 86108]

17.

Smith U, Gale EAM. Does diabetes therapy influence the risk of cancer?. Diabetologia 2009;52:1699-708. [Ref.ID 86102]

18.

Ball DR, Kamel Y, Perkins V. Entanglement in Scotland. BMJ 2009;338:494. [Ref.ID 85382]

19.

Cornell SJ. UK rationing of new medicines. NICE should follow example of Scottish Medicines Consortium. BMJ 2009;338:430. [Ref.ID 85324]

20.

Stanley AJ, Ashley D, Dalton HR, Mowat C, Gaya DR, Thompson E, Warshow U, Groome M, Cahill A, Benson G, Blatchford O, Murray W. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet 2009;373:42-7. [Ref.ID 84955]